欢迎来到 Athens Research&Technology中国区代理商/公司/官网
全国咨询热线: 13212737804
联系我们

地址:武汉市洪山区光谷大道35号光谷总部国际时代 二期1栋1301

电话:18995651644

传真:18771149750

邮箱:sales@amyjet.com

新闻中心
Anogen.jpg

Anogen-Yes Biotech Laboratories Ltd. 创建于1989年, 位于加拿大多伦多近郊的著名高科技城市密西沙加市。Anogen是加拿大逸士生物技术研究有限公司在国际上的市场经销部门。Anogen-Yes Biotech Laboratories Ltd.研发和生产各种新颖抗体及有关产品,应用广泛的技术平台设计和开发各种单克隆抗体、多克隆抗体、基因工程/人源化抗体、免疫检验用配对抗体、免疫球蛋白、活性多肽、酶联免疫试剂盒[ELISA]、斑点酶联免疫试剂盒[Elispots]和基因重组蛋白质等等。 这些产品主要用于生命科学研究和各种疾病的诊断和防治,包括炎症和自身免疫性疾病、心血管病和癌症等。

 

Anogen is the trade name of Yes Biotech Laboratories Ltd., a Canadian biopharmaceutical company based in Mississauga, Ontario. Founded in 1989, Anogen-Yes Biotech specializes in developing and manufacturing monoclonal antibodies, recombinant proteins, synthetic bioactive peptides, and Enzyme linked immunosorbent assay (ELISA) kits for research as well as diagnostic and therapeutic use.[1] It is also committed to seeking medical treatment of cancer, autoimmune, inflammatory and cardiovascular diseases by developing antibody-based biopharmaceuticals.

 

Anogen的主要产品包括:

Monoclonal Antibodies

Polyclonal Antibodies

Matched Antibody Pairs

ELISA Kits

 

按照研究领域细分:

Inflammatory & Growth Factors

Cell Biology & Molecular Biology

Immunoassay Reagents

Infection & Toxin

Coagulation Factors

Hormone

Neurological Disorder

Tumor Research


品名货号规格
mAb anti-Human TNF-α, CH8810MO-C40003A0.1 mg
mAb anti-Human TNF-α, CH8820, CaptureMO-C40003B0.1 mg
mAb anti-Human TNF-α, C2H9MO-C40003D0.1 mg
mAb anti-Human TNF-α, B1E4, DetectorMO-C40003E0.1 mg
mAb anti-Human TNF-α, C2A7MO-C40003F0.1 mg
mAb anti-Human TNF-α, C5G7MO-C40003G0.1 mg
mAb anti-Human TNF-α, C4C7MO-C40003H0.1 mg
mAb anti-Human IFN-γ, 315MO-C40004D0.1 mg
mAb anti-Human IFN-γ, 165MO-C40004E0.1 mg
mAb anti-Human IFN-γ, 23MO-C40004F0.1 mg
mAb anti-Human CCR1, 293MO-C40005A0.1 mg
mAb anti-Human TGF-β, TB21MO-C40009A0.1 mg
mAb anti-Human TGF-β, 2C5MO-C40009B0.1 mg
mAb anti-Human TGF-β, 2C6MO-C40009D0.1 mg
mAb anti-Human TGF-β, 2E6MO-C40009E0.1 mg
mAb anti-Human TGF-β, 8C4MO-C40009F0.1 mg
mAb anti-Human IL-8, I8-S2, CaptureMO-C40017A0.1 mg
mAb anti-Human IL-8, I8-60, DetectorMO-C40017D0.1 mg
mAb anti-Human IL-8, I8-61MO-C40017E0.1 mg
mAb anti-Human IL-8, 257MO-C40017F0.1 mg
mAb anti-Human IL-8, 807MO-C40017G0.1 mg
mAb anti-Human MCP-1, S8MO-C40021A0.1 mg
mAb anti-Human MCP-1, S14, CaptureMO-C40021B0.1 mg
mAb anti-Human MCP-1, S101, DetectorMO-C40021D0.1 mg
mAb anti-Human MCP-1, 9G10MO-C40021E0.1 mg
mAb anti-Human MCP-1, S382MO-C40021F0.1 mg
mAb anti-Human SAA, 115, CaptureMO-C40028A0.1 mg
mAb anti-Human SAA, 513MO-C40028D0.1 mg
mAb anti-Human SAA, 607, DetectorMO-C40028E0.1 mg
mAb anti-Human SAA, 291MO-C40028G0.1 mg
mAb anti-Human SAA, 504MO-C40028H0.1 mg
mAb anti-Human SAA, 585MO-C40028J0.1 mg
mAb anti-Human SAA, 426MO-C40028K0.1 mg
mAb anti-Human SAA, 38MO-C40028L0.1 mg
mAb anti-Human SAA, 132MO-C40028M0.1 mg
mAb anti-Human SAA, S3MO-C40028N0.1 mg
mAb anti-Human IL-1β, S1H12MO-C40029A0.1 mg
mAb anti-Human IL-1β, S1B7MO-C40029B0.1 mg
mAb anti-Human IL-1β, S3F12MO-C40029G0.1 mg
mAb anti-Human IL-1β, 464MO-C40029H0.1 mg
mAb anti-Human IL-2, 5A8,MO-C40032A0.1 mg
mAb anti-Human IL-2, 9F9,MO-C40032B0.1 mg
mAb anti-Human IL-2, 10C4MO-C40032C0.1 mg
mAb anti-Human IL-2, 8C2MO-C40032D0.1 mg
mAb anti-Human IL-2, 6F11MO-C40032E0.1 mg
mAb anti-Human IL-2, 6B1MO-C40032F0.1 mg
mAb anti-Human EGF, S-21MO-C40044A0.1 mg
mAb anti-Human EGF, S-120MO-C40044B0.1 mg
mAb anti-Human EGF, S-134, CaptureMO-C40044D0.1 mg
mAb anti-Human EGF, S-145MO-C40044E0.1 mg
mAb anti-Human EGF, S-146, DetectorMO-C40044F0.1 mg
mAb anti-Human EGF, S-147MO-C40044G0.1 mg
mAb anti-Human EGF, S-177MO-C40044H0.1 mg
mAb anti-Human G-CSFR, S-1252MO-C40045A0.1 mg
mAb anti-Human G-CSFR, S-1268MO-C40045B0.1 mg
mAb anti-Human G-CSFR, S-1284MO-C40045D0.1 mg
mAb anti-Human G-CSFR, S-1374MO-C40045E0.1 mg
mAb anti-Human G-CSFR, S-425MO-C40045F0.1 mg
mAb anti-Human G-CSFR, S-1390MO-C40045G0.1 mg
mAb anti-Human bFGF, F-343MO-C40046A0.1 mg
mAb anti-Human bFGF, F-74MO-C40046B0.1 mg
mAb anti-Human bFGF, F-474MO-C40046F0.1 mg
mAb anti-Human bFGF, F-3MO-C40046H0.1 mg
mAb anti-Human EPO, 85MO-C40047A0.1 mg
mAb anti-Human M-CSF, 116MO-C40048A0.1 mg
mAb anti-Human M-CSF, 692MO-C40048B0.1 mg
mAb anti-Human M-CSF, 21MO-C40048D0.1 mg
mAb anti-Human MIP-1α, 116MO-C40051A0.1 mg
mAb anti-Human MIP-1α, 125MO-C40051D0.1 mg
mAb anti-Human MIP-1α, 548MO-C40051F0.1 mg
mAb anti-Human MIP-1α, 199MO-C40051G0.1 mg
mAb anti-Human MIP-1α, 400MO-C40051L0.1 mg
mAb anti-Human MIP-1α, 103MO-C40051M0.1 mg
mAb anti-Human MIP-1α, 376MO-C40051N0.1 mg
mAb anti-Human MIP-1α, 426MO-C40051P0.1 mg
mAb anti-Human MCP-3, 113, DetectorMO-C40088A0.1 mg
mAb anti-Human MCP-3, 343MO-C40088B0.1 mg
mAb anti-Human MCP-3, 490MO-C40088D0.1 mg
mAb anti-Human MCP-3, 768MO-C40088E0.1 mg
mAb anti-Human MCP-3, 1057MO-C40088F0.1 mg
mAb anti-Human MCP-3, 542, CaptureMO-C40088G0.1 mg
mAb anti-Human MCP-3, 1015MO-C40088H0.1 mg
mAb anti-Human IL-16, 59MO-C40089G0.1 mg
mAb anti-Human IL-16, 210MO-C40089H0.1 mg
mAb anti-Human IL-16, 323, DetectorMO-C40089J0.1 mg
mAb anti-Human IL-16, 398, CaptureMO-C40089K0.1 mg
mAb anti-Human IL-16, 568MO-C40089M0.1 mg
mAb anti-Human IL-16, 572MO-C40089N0.1 mg
mAb anti-Human GM-CSF, 29MO-C40090A0.1 mg
mAb anti-Human GM-CSF, 59, CaptureMO-C40090B0.1 mg
mAb anti-Human GM-CSF, 429, DetectorMO-C40090D0.1 mg
mAb anti-Human GM-CSF, 204MO-C40090E0.1 mg
mAb anti-Human GM-CSF, 489MO-C40090F0.1 mg
mAb anti-Human GM-CSF, 120MO-C40090G0.1 mg
mAb anti-Human GM-CSF, 26MO-C40090H0.1 mg
mAb anti-Human GM-CSF, 174MO-C40090K0.1 mg
mAb anti-Human GM-CSF, S333MO-C40090L0.1 mg
mAb anti-Human IL-6, 2E10MO-C40091B0.1 mg
mAb anti-Human IL-6, 8E10MO-C40091C0.1 mg
mAb anti-Human IL-6, 5G8MO-C40091D0.1 mg
mAb anti-Human IL-6, 1B6MO-C40091E0.1 mg
mAb anti-Human IL-6, 1E3MO-C40091F0.1 mg
mAb anti-Human IL-6, 6D7MO-C40091G0.1 mg
mAb anti-Human IL-6, 9D8MO-C40091H0.1 mg
mAb anti-Human IL-10, 4H2MO-C40092A0.1 mg
mAb anti-Human IL-10, 6D2MO-C40092B0.1 mg
mAb anti Human IL-17A clone 4C1, CaptureMO-C40093A0.1mg
mAb anti Human IL-17A clone 2F3MO-C40093B0.1mg
mAb anti Human IL-17A clone 8H7MO-C40093C0.1mg
mAb anti Human IL-17A clone 5B4MO-C40093D0.1mg
mAb anti Human IL-17A clone 1E2MO-C40093E0.1mg
mAb anti Human IL-17A clone 2D11MO-C40093H0.1mg
mAb anti Human IL-17A clone 3C1MO-C40093I0.1mg
mAb anti Human IL-17A clone 3H11, DetectorMO-C40093K0.1mg
mAb anti Human IL-17A clone 5A9MO-C40093M0.1mg
mAb anti Human IL-17A clone 6F12MO-C40093O0.1mg
mAb anti Human IL-17A clone 7F10MO-C40093S0.1mg
mAb anti Human IL-17A clone 10F9MO-C40093W0.1mg
mAb anti Human IL-18 clone 2A10, CaptureMO-C40094A0.1mg
mAb anti Human IL-18 clone 10H4, DetectorMO-C40094B0.1mg
mAb anti human IL-18 clone 10H4, Tracer (Biotin Labeled)MO-C40094TB0.1 mL
mAb anti Human IL-15 clone 5E8, CaptureMO-C40095A0.1mg
mAb anti Human IL-15 clone B1H6, DetectorMO-C40095B0.1mg
mAb anti-human LIF, Clone 2C6MO-C40096A0.1mg
mAb anti-human LIF, Clone 3F4MO-C40096B0.1mg
mAb anti-human LIF, Clone 8B10MO-C40096C0.1mg
mAb anti-DYKDDDDK (Flag) Tag, Flag.10F4MO-H40001B0.1 mg
mAb anti-GAPDH, H8MO-H40002A0.1 mg
mAb anti-HA Tag, HA52MO-H40004A0.1 mg
mAb anti-His Tag, 10A12MO-H40005B0.1 mg
mAb anti-Myc Tag, MycA7MO-H40006A0.1 mg
mAb anti-V5 Tag, V531MO-H40007A0.1 mg
mAb anti-HIV-1 P24 (Core Protein), 473, DetectorMO-I40002A0.1 mg
mAb anti-HIV-1 P24 (Core Protein), 163MO-I40002C0.1 mg
mAb anti-HIV-1 P24 (Core Protein), 340, CaptureMO-I40002D20.1 mg
mAb anti-HIV-1 P24 (Core Protein), 587, 0.1 mgMO-I40002E0.1 mg
mAb anti-HIV-1 P24 (Core Protein), 425MO-I40002I0.1 mg
mAb anti-HIV-1 P24 (Core Protein), 1027MO-I40002J0.1 mg
mAb anti-HIV-1 P24 (Core Protein), 287MO-I40002N0.1 mg
mAb anti-HIV-1 P24 (Core Protein), 161MO-I40002P0.1 mg
mAb anti-HBsAg, RM-1MO-I40013A0.1 mg
mAb anti-HCV Core Protein, A1/3D1MO-I40015A0.1 mg
mAb anti-HCV Core Protein, B2MO-I40015B0.1 mg
mAb anti-HCV Core Protein, C3MO-I40015E0.1 mg
mAb anti-HCV NS-4, 7B7/5G9MO-I40016B0.1 mg
mAb anti-HCV NS-4, 5D4/10E7MO-I40016D0.1 mg
mAb anti-HCV NS-4, 7E11MO-I40016F0.1 mg
mAb anti-HCV NS-4, 202MO-I40016J0.1 mg
mAb anti-HCV NS-4, 101MO-I40016K0.1 mg
mAb anti-HCV NS-4, 174MO-I40016L0.1 mg
mAb anti-HCV NS-4, 497MO-I40016M0.1 mg
mAb anti-HCV NS-3, 70-13MO-I40018A0.1 mg
mAb anti-HCV NS-3, 1-5MO-I40018B0.1 mg
mAb anti-HCV NS-3, 12-15MO-I40018D0.1 mg
mAb anti-HCV NS-3, 5-11MO-I40018E0.1 mg
mAb anti-HCV NS-3, 24-8MO-I40018F0.1 mg
mAb anti-HCV NS-3, 20-8MO-I40018G0.1 mg
mAb anti-HCV NS-3, 113MO-I40018H0.1 mg
mAb anti-HCV NS-3, 281MO-I40018J0.1 mg
mAb anti-HCV NS-3, 806MO-I40018K0.1 mg
mAb anti-HCV NS-3, 5MO-I40018L0.1 mg
mAb anti-HCV NS-3, 328MO-I40018M0.1 mg
mAb anti-HCV NS-3, 251MO-I40018N0.1 mg
mAb anti-HCV NS-3, 242MO-I40018P0.1 mg
mAb anti-HCV NS-3, 133MO-I40018Q0.1 mg
mAb anti-HEV, S-13MO-I40019B0.1 mg
mAb anti-HEV, 4H5MO-I40019C0.1 mg
mAb anti-HEV, 2H6MO-I40019D0.1 mg
mAb anti-HEV, 2H2MO-I40019E0.1 mg
mAb anti-HEV, 1B6MO-I40019F0.1 mg
mAb anti-HEV, 5H4MO-I40019G0.1 mg
mAb anti-HP CagA, 10E9,MO-I40020A0.1 mg
mAb anti-HP CagA, 5H10MO-I40020B0.1 mg
mAb anti-HP CagA, 5C6MO-I40020C0.1 mg
mAb anti-HP CagA, 3C10,MO-I40020D0.1 mg
mAb anti-HP CagA, 3C1MO-I40020E0.1 mg
mAb anti-TB 38KD Antigen, D2G2MO-I40021A0.1 mg
mAb anti-TB 38KD Antigen, C12H11MO-I40021B0.1 mg
mAb anti-TB 38KD Antigen, C11B10MO-I40021C0.1 mg
mAb anti-TB 38KD Antigen, B12F8MO-I40021D0.1 mg
mAb anti-TB 38KD Antigen, A11D2MO-I40021E0.1 mg
mAb anti-TB 38KD Antigen, A2H8MO-I40021F0.1 mg
mAb anti-Human CD3, JXT3MO-L40001A0.1 mg
Rat anti-Mouse CD4, JXYT4MO-L400260.1 mg
Rat anti-Mouse CD8, JXYT8MO-L400270.1 mg
mAb anti-Human CD11α, A11MO-L400280.1 mg
mAb anti-Human HLA-ABC, LY5.1MO-L400330.1 mg
mAb anti-Human CD71 Transferrin Receptor, CY-TFRMO-L400420.1 mg
mAb anti-Human PD-1 / CD279, 1C4MO-L40043A0.1 mg
mAb anti-Human PD-1 / CD279, 7C9, CaptureMO-L40043B0.1 mg
mAb anti-Human PD-1 / CD279, 9E11MO-L40043E0.1 mg
mAb anti-Human PD-1 / CD279, 9B4MO-L40043F0.1 mg
mAb anti-Human PD-1 / CD279, B1C4MO-L40043G0.1 mg
mAb anti-Human PD-1 / CD279, 7G12, DetectorMO-L40043L0.1 mg
mAb anti-Human PD-1 / CD279, 2H7MO-L40043M0.1 mg
mAb anti Human PD-L1, clone 6A5MO-L40044E0.1 mg
mAb anti Human PD-L1 clone 8C12MO-L40044F0.1 mg
mAb anti Human PD-L1 clone 12B4, DetectorMO-L40044I0.1 mg
mAb anti Human PD-L1 clone 11D11MO-L40044M0.1 mg
mAb anti Human PD-L1 clone 15G3, CaptureMO-L40044N0.1 mg
mAb anti Human PD-L1 clone 12D9MO-L40044O0.1 mg
mAb anti Human PD-L1 clone 15F2MO-L40044R0.1 mg
mAb anti Human PD-L1, clone 10B12MO-L40044S0.1 mg
mAb anti Human CD47, clone 1G10MO-L40045A0.1 mg
mAb anti Human CD47, clone 8H7MO-L40045B0.1 mg
mAb anti Human CD47, clone 9F10MO-L40045C0.1 mg
mAb anti Human CD44, clone 2G7MO-L40046A0.1 mg
mAb anti Human CD44, clone 3C7MO-L40046B0.1 mg
mAb anti-hCG-α, CH5MO-M40010A0.1 mg
mAb anti-hCG-α, CH7MO-M40010B0.1 mg
mAb anti-TRICHOSANTHIN (TCST), TCST-1, 0.1 mgMO-M40011A0.1 mg
mAb anti-hGH, YC6, CaptureMO-M40012A0.1 mg
mAb anti-Human Ig Kappa Light Chain, YCK1MO-M400200.1 mg
mAb anti-Human B2MG, D6E4MO-M40021B0.1 mg
mAb anti-Human B2MG, D2E9, CaptureMO-M40021C0.1 mg
mAb anti-Human B2MG, D6D1MO-M40021D0.1 mg
mAb anti-Human B2MG, D2A10MO-M40021E0.1 mg
mAb anti-Human B2MG, D3A2, DetectorMO-M40021F0.1 mg
mAb anti-human CRP, 63F4, CaptureMO-M40023A0.1 mg
mAb anti-human CRP, 67A1MO-M40023B0.1 mg
mAb anti-human CRP, N1G1MO-M40023D0.1 mg
mAb anti-human CRP, S5G1MO-M40023E0.1 mg
mAb Rat anti-Aflatoxin, 1C6, 0.1 mgMO-M40025A0.1 mg
mAb Rat anti-Aflatoxin, 1E6, 0.1 mgMO-M40025B0.1 mg
mAb Rat anti-Aflatoxin, 2E4MO-M40025D0.1 mg
mAb anti-Human Albumin, S4D6MO-M400360.1 mg
mAb anti-Human Factor IX, F9-1, .01 mgMO-M400370.1 mg
mAb anti-Human Protein C, HLW-C, 0.1 mgMO-M400380.1 mg
mAb anti-Human Factor X, F10-1, 0.1 mgMO-M400390.1 mg
mAb anti-Human GP IIb/IIIa, 237, 0.1 mgMO-M40040A0.1 mg
mAb anti-Human GP IIb/IIIa, 474, 0.1 mgMO-M40040B0.1 mg
mAb anti-Human GP IIb/IIIa, Y8MO-M40040D0.1 mg
mAb anti-Human GP IIb/IIIa, 700MO-M40040E0.1 mg
mAb anti-Human GP IIb/IIIa, 585MO-M40040F0.1 mg
mAb anti-Human GP IIb/IIIa, 8MO-M40040H0.1 mg
mAb anti-Human GP IIb/IIIa, 291MO-M40040J0.1 mg
mAb anti-Human GP IIb/IIIa, 262MO-M40040N0.1 mg
mAb anti-Human GP IIb/IIIa, 71MO-M40040Q0.1 mg
mAb anti-Human GP IIb/IIIa, 128MO-M40040S0.1 mg
mAb anti-Staphylococcal Enterotoxin B [SEB], 0.1 mgMO-M400410.1 mg
mAb anti-Human PTP1-C, PTY6MO-M40043A0.1 mg
mAb anti-Human PTP1-C, PTY11MO-M40043B0.1 mg
mAb anti-Human PTP1-C, PTY15MO-M40043D0.1 mg
mAb anti-Human PTP1-C, PTY10MO-M40043E0.1 mg
mAb anti-Human PTP1-C, PTY13MO-M40043F0.1 mg
mAb anti-human TSH, TSH-2, DetectorMO-M40046A0.1 mg
mAb anti-human TSH, TSH-1, CaptureMO-M40046B0.1 mg
mAb anti-Human Prolactin, PRL-1, CaptureMO-M40047B0.5 mg
mAb anti-Human LH, LH-1, CaptureMO-M40048B0.5 mg
mAb anti-hCG, HCG-1, CaptureMO-M40049B0.5 mg
mAb anti-Human FSH, FSH-1, CaptureMO-M40050B0.5 mg
mAb anti-Human Raf-1, 410MO-M40091E0.5 mg
mAb anti-Human Raf-1, 540MO-M40091G0.5 mg
mAb anti-Human Raf-1, 863MO-M40091J0.5 mg
mAb anti-Human Raf-1, 163MO-M40091M0.5 mg
mAb anti-Human NSE, 145MO-M40092A0.5 mg
mAb anti-Human NSE, 1G6MO-M40092B0.5 mg
mAb anti-Human NSE, 171MO-M40092C0.5 mg
mAb anti-Amyloid β Peptide 42, CA9 3B3MO-M40093A0.1 mg
mAb anti-Amyloid β Peptide 42, CA9 10C11, DetectorMO-M40093B0.5 mg
mAb anti-Amyloid β Peptide 42, CA9 3F8MO-M40093D0.5 mg
mAb anti-Amyloid β Peptide N-terminal, NT 3F5MO-M40094A0.5 mg
mAb anti-Amyloid β Peptide N-terminal, NT 1H3MO-M40094B0.5 mg
mAb anti-Amyloid β Peptide N-terminal, NT 6C8MO-M40094C0.5 mg
mAb anti-Amyloid β Peptide N-terminal, NT 5B8, CaptureMO-M40094D0.5 mg
mAb anti-Amyloid β Peptide N-terminal, NT 4A2MO-M40094E0.5 mg
mAb anti-Amyloid β Peptide N-terminal, NT 7H7MO-M40094F0.5 mg
mAb anti-Amyloid β Peptide N-terminal, NT 5A4MO-M40094G0.5 mg
mAb anti-Amyloid β Peptide N-terminal, NT 4B7MO-M40094H0.5 mg
mAb anti-Amyloid β Peptide N-terminal, NT 7G10MO-M40094I0.5 mg
mAb anti-Amyloid β Peptide N-terminal, NT 1F10MO-M40094J0.5 mg
mAb anti-Amyloid β Peptide 40, CV9 7B10, DetectorMO-M40095A0.1 mg
mAb anti-Amyloid β Peptide 40, CV9 8B2MO-M40095B0.1 mg
mAb anti-Amyloid β Peptide 40, 4B1MO-M40095C0.1 mg
mAb anti-Human α1-antitrypsin, 5G5MO-M40096A0.1 mg
mAb anti-Human α1-antitrypsin, 9F2MO-M40096B0.1 mg
mAb anti-Human α-Synuclein, 4H11MO-M40097A0.1 mg
mAb anti-Human α-Synuclein, 4C1MO-M40097B0.1 mg
mAb anti-Human α-Synuclein, 4B4MO-M40097C0.1 mg
mAb anti-Human α-Synuclein, 8F12MO-M40097D0.1 mg
mAb anti-Human α-Synuclein, 9A9MO-M40097E0.1 mg
mAb anti-Human α1-antichymotrypsin, 3E11MO-M40098A0.1 mg
mAb anti-Human α1-antichymotrypsin, B2B3MO-M40098B0.1 mg
mAb anti-Human α1-antichymotrypsin, B4H12MO-M40098C0.1 mg
mAb anti-Human α1-antichymotrypsin, B5B11MO-M40098D0.1 mg
mAb anti-Human α1-antichymotrypsin, B7B10MO-M40098E0.1 mg
mAb anti-Human α1-antichymotrypsin, B7H2MO-M40098F0.1 mg
mAb anti-Thr181 Phosphorylated Tau, 1A4MO-M40099A0.1 mg
mAb anti-Thr181 Phosphorylated Tau, 7G9MO-M40099B0.1 mg
mAb anti-Thr181 Phosphorylated Tau, 9B4MO-M40099C0.1 mg
mAb anti-Thr181 Phosphorylated Tau, 2A4MO-M40099D0.1 mg
mAb anti-human Thr212 Thr217 double phosphorylated Tau, 8E1MO-M40100A0.1 mg
mAb anti-human Thr212 Thr217 double phosphorylated Tau, 1G8MO-M40100B0.1 mg
mAb anti-human Thr212 Thr217 double phosphorylated Tau, 4C1MO-M40100C0.1 mg
mAb anti-human Thr212 Thr217 double phosphorylated Tau, 3B12MO-M40100D0.1 mg
mAb anti-human Thr212 Thr217 double phosphorylated Tau, 4H1MO-M40100E0.1 mg
mAb anti-human Thr212 Thr217 double phosphorylated Tau, 4H11MO-M40100F0.1 mg
mAb anti-human Thr212 Thr217 double phosphorylated Tau, 5C11MO-M40100G0.1 mg
mAb anti-human Thr212 Thr217 double phosphorylated Tau, 10G9MO-M40100H0.1 mg
mAb anti-LCRMP4, 5H5MO-M40101A/
mAb anti-LCRMP4, 2H7MO-M40101B/
mAb anti-LCRMP4 , 7E1MO-M40101C/
mAb anti-Human Phospho-STAT5b [p-Y699], A4B9MO-P40001A0.1 mg
mAb anti-Human Phospho-STAT5b [p-Y699], A2H6MO-P40001B0.1 mg
mAb anti-Human Phospho-ELK-1 [p-S383], B4A12MO-P40002A0.1 mg
mAb anti-Human Phospho-ELK-1 [p-S383], D7H2MO-P40002B0.1 mg
mAb anti-Human Phospho-CREB [p-S133], A3A4MO-P40003A0.1 mg
mAb anti-Human Phospho-CREB [p-S133], B1C4MO-P40003B0.1 mg
mAb anti-Human FPRL-1 C-terminal, C4F9MO-P40006A0.1 mg
mAb anti-Human FPRL-1 C-terminal, B4D9B10MO-P40006B0.1 mg
mAb anti-Human FPRL-1 2nd extracellular loop, 3D7MO-P40007A0.1 mg
mAb anti-Human FPRL-1 2nd extracellular loop, B7H10MO-P40007B0.1 mg
mAb anti-Human Lung Carcinoma, CHALU2MO-T40005B0.1 mg
mAb anti-Human Lung Carcinoma, 3504MO-T40005C0.1 mg
mAb anti-Human Hepatocellular Carcinoma, CHALV1MO-T40006A0.1 mg
mAb anti-Human AFP, AFP-Y2, DetectorMO-T40007A0.1 mg
mAb anti-Human AFP, AFP-Y1, CaptureMO-T40007B0.1 mg
mAb anti-Human BPH, YBPH-1MO-T40008A0.1 mg
mAb anti-Human BPH, YBPH-2MO-T40008B0.1 mg
mAb anti-Human PML, B3E9MO-T40010A0.1 mg
mAb anti-Human PML, B4C8MO-T40010B0.1 mg
mAb anti-CA 125, 110MO-T40012A0.1 mg
mAb anti-CA 125, 76MO-T40012B0.1 mg
mAb anti-CA 125, 23MO-T40012C0.1 mg
mAb anti-CA 125, 15MO-T40012D0.1 mg
mAb anti-CA 125MO-T40012E0.1 mg
mAb anti-CA50, 93MO-T40014A0.1 mg
mAb anti-CA50, 826MO-T40014B0.1 mg
mAb anti- human carbohydrate antigen 19-9 (CA 19-9) ,8E2 (Free Sample Available)MO-T40015A0.1 mg
mAb anti- human carbohydrate antigen 19-9 (CA 19-9) ,9B2 (Free Sample Available)MO-T40015B0.1 mg
mAb anti- human carbohydrate antigen 19-9 (CA 19-9) ,1A5 (Free Sample Available)MO-T40015C0.1 mg
mAb anti- human carbohydrate antigen 19-9 (CA 19-9) ,4E11 (Free Sample Available)MO-T40015D0.1 mg
mAb anti- human carbohydrate antigen 19-9 (CA 19-9) ,9E1 (Free Sample Available)MO-T40015E0.1 mg
mAb anti- human carbohydrate antigen 19-9 (CA 19-9) ,7C4 (Free Sample Available)MO-T40015F0.1 mg
mAb anti- human carbohydrate antigen 19-9 (CA 19-9) ,7E6 (Free Sample Available)MO-T40015G0.1 mg
mAb anti-Human Colorectal Carcinoma, Y94MO-T400220.1 mg
mAb anti-Human Colorectal Carcinoma/CD3, BS-1MO-T400350.1 mg
mAb anti-Human CEA, CEA-Y2, DetectorMO-T40051A0.1 mg
mAb anti-Human CEA, CEA-Y1, CaptureMO-T40051B0.1 mg
mAb anti-Human Free PSA, 103, DetectorMO-T40052A0.1 mg
mAb anti-Human Free PSA, 108, CaptureMO-T40052B0.1 mg
mAb anti-Human PSA, CHYH1, CaptureMO-T40081A0.1 mg
mAb anti-Human PSA, CHYH2, DectectorMO-T40081B0.1 mg
mAb anti-Human PMA, YPMA-1MO-T40083A0.1 mg
mAb anti-Human PMA, YPMA-2MO-T40083B0.1 mg
mAb anti-Human PSP, YPSP-1MO-T40085A0.1 mg
mAb anti-Human PSP, YPSP-2MO-T40085B0.1 mg
mAb anti-Human PSP, YPSP-3MO-T40085C0.1 mg
mAb anti-Human PSP, YPSP-4MO-T40085D0.1 mg
mAb anti-Human PSMA, YPSMA-1MO-T40086A0.1 mg
mAb anti-Human PSMA, YPSMA-2MO-T40086B0.1 mg
mAb anti-Human PSMA, 4H11MO-T40086C0.1 mg
mAb anti-Human PSMA, 7F3MO-T40086D0.1 mg
mAb anti-Human PTMA, 8H12MO-T40087A0.1 mg
mAb anti-Human PTMA, 9A10MO-T40087B0.1 mg
mAb anti-Human PTMA, 6A3MO-T40087C0.1 mg
mAb anti-Human PTMA, 4G2MO-T40087D0.1 mg
mAb anti-Human PTMA, 5A10MO-T40087E0.1 mg
mAb anti-Human PTMA, 6H7MO-T40087F0.1 mg
mAb anti-Human PTMA, 1F2, CaptureMO-T40087G0.1 mg
mAb anti-Human PTMA, 4C3MO-T40087H0.1 mg
mAb anti-Human PTMA, 4A7, DetectorMO-T40087I0.1 mg
mAb anti-Human S100A7 (psoriasin), 9A4MO-T40088A0.1 mg
mAb anti-Human S100A7 (psoriasin), 2E6MO-T40088B0.1 mg
mAb anti-Human S100A7 (psoriasin), 1A10MO-T40088C0.1 mg
mAb anti-Human S100A7 (psoriasin), 5C2MO-T40088D0.1 mg
mAb anti-Human S100A7 (psoriasin), 10H9MO-T40088E0.1 mg
mAb anti-Human S100A7 (psoriasin), 2A3MO-T40088F0.1 mg
mAb anti-Human S100A7 (psoriasin), 2E5MO-T40088G0.1 mg
mAb anti-Human S100A7 (psoriasin), 5H12MO-T40088H0.1 mg
mAb anti-Human S100A7 (psoriasin), 9C7MO-T40088I0.1 mg
mAb anti-Human S100A7 (psoriasin), 9D5MO-T40088J0.1 mg
mAb anti-Human S100A7 (psoriasin), 3E7MO-T40088K0.1 mg
Human PSA ELISA KitEL1000596 wells
Human IL-8 ELISA KitEL1000896 wells
Human MCAF / MCP-1 ELISA KitEL1000996 wells
Human EGF ELISA KitEL1001096 wells
Human LH ELISA KitEL1001196 wells
Human TSH ELISA KitEL1001296 wells
Neonatal TSH ELISA KitEL10012N96 wells
Ultra-Sensitive Human TSH ELISA KitEL10012U96 wells
Human FSH ELISA KitEL1001396 wells
Human Prolactin ELISA KitEL1001496 wells
Human SAA ELISA KitEL1001596 wells
Human SAA ELISA Kit (2nd Generation)EL10015L96 wells
Human MCP-3 ELISA KitEL1001696 wells
Human TNF-α ELISA KitEL1001996 wells
Human GM-CSF ELISA KitEL1002096 wells
Human IL-16 ELISA KitEL1002196 wells
High Sensitivity Human CRP ELISA KitEL10022hs96 wells
Human IL-6 ELISA KitEL1002396 wells
Human IFN-γ ELISA KitEL1002496 wells
Human IL-2 ELISA KitEL1002596 wells
Human IL-4 ELISA KitEL1002696 wells
Human IL-10 ELISA KitEL1002796 wells
Human IL-1β ELISA KitEL1002896 wells
Human TGF-β1 ELISA KitEL1002996 wells
Human Growth Hormone (hGH) ELISA Kit/Hormone ElisaEL1003096 wells
High Sensitivity Human Growth Hormone (H-hGH) ELISA KitEL10030H96 wells
Human Chorionic Gonadotropin (hCG) ELISA KitEL1003196 wells
Human IL-12 (P70) ELISA KitEL1003296 wells
Human IL-2 sRα ELISA KitEL1003396 wells
Human IL-6 sR ELISA KitEL1003496 wells
Human IL-5 ELISA KitEL1003596 wells
HAMA ELISA KitEL1003696 wells
Human IL-13 Rα2 ELISA KitEL1003996 wells
Human IL-1α ELISA KitEL1004096 wells
Human IL-7 ELISA KitEL1004196 wells
Human IL-11 ELISA KitEL1004296 wells
Human IL-15 ELISA KitEL1004496 wells
Human M-CSF ELISA KitEL1004696 wells
Human TNF-β ELISA KitEL1004796 wells
Human bFGF ELISA KitEL1004896 wells
Human Alphafetoprotein (AFP) ELISA KitEL1004996 wells
Human B2MG ELISA KitEL1005196 wells
Human Carcinoembryonic Antigen (CEA) ELISA KitEL1005296 wells
Human IL-17A ELISA KitEL1005396 wells
Human IL-13 ELISA KitEL1005496 wells
Human IL-22 ELISA KitEL1005596 wells
Human IL-9 ELISA KitEL1005696 wells
Human Amyloid Beta Peptide 42 ELISA KitEL1005796 wells
Human Programmed Death-Ligand 1 (PD-L1) ELISA KitEL1005896 wells
Human Programmed Death-1 (PD-1) ELISA KitEL1005996 wells
Human IL-18 ELISA KitEL1006096 wells
Multiplex Human Cytokine ELISA Kit (Inflammatory)EM1000196 wells
Multiplex Human Cytokine ELISA Kit (M1/M2/MDSC Cytokines)EM1000296 wells
Multiplex Human Cytokine ELISA Kit (Th1/Th2/Th17)EM1000396 wells
Mouse IL-17A ELISA KitMEC100196 wells
Mouse IFN-γ ELISA KitMEC100296 wells
Mouse TNF-α ELISA KitMEC100396 wells
Mouse GM-CSF ELISA KitMEC100496 wells
Mouse MCP-1 ELISA KitMEC100596 wells
Mouse IL-2 ELISA KitMEC100696 wells
Mouse IL-5 ELISA KitMEC100796 wells
Mouse IL-6 ELISA KitMEC100896 wells
Mouse IL-4 ELISA KitMEC100996 wells
Mouse IL-1β ELISA KitMEC101096 wells
Mouse IL-1α ELISA KitMEC101196 wells
Mouse TGF-β1 ELISA KitMEC101296 wells
pAb anti-Human CRP, Tracer (HRP Labeled)AI20009P0.2 mL
mAb anti-Human TNF-α, CH8820, CaptureMO-C40003B0.1 mg
mAb anti-Human TNF-α, B1E4, DetectorMO-C40003E0.1 mg
mAb anti-Human TNF-α, B1E4, Tracer (HRP Labeled)MO-C40003T0.2 mL
mAb anti-Human TNF-α, B1E4, Tracer (Biotin Labeled)MO-C40003TB0.1 mL
mAb anti-Human IL-8, I8-S2, CaptureMO-C40017A0.1 mg
mAb anti-Human IL-8, I8-60, DetectorMO-C40017D0.1 mg
mAb anti-Human IL-8, I8-60, Tracer (HRP Labeled)MO-C40017T0.2 mL
mAb anti-Human IL-8, I8-60, Tracer (Biotin Labeled)MO-C40017TB0.1 mL
mAb anti-Human MCP-1, S14, CaptureMO-C40021B0.1 mg
mAb anti-Human MCP-1, S101, DetectorMO-C40021D0.1 mg
mAb anti-Human MCP-1, S101, Tracer (HRP Labeled)MO-C40021T0.2 mL
mAb anti-Human MCP-1, S101, Tracer (Biotin Labeled)MO-C40021TB0.1 mL
mAb anti-Human SAA, 115, CaptureMO-C40028A0.1 mg
mAb anti-Human SAA, 607, DetectorMO-C40028E0.1 mg
mAb anti-Human SAA, 607, Tracer (HRP Labeled), 0.2mLMO-C40028T0.2 mL
mAb anti-Human SAA, 607, Tracer (Biotin Labeled), 0.1mLMO-C40028TB0.1 mL
mAb anti-Human EGF, S-134, CaptureMO-C40044D0.1 mg
mAb anti-Human EGF, S-146, DetectorMO-C40044F0.1 mg
mAb anti-Human EGF, S-146, Tracer (HRP Labeled)MO-C40044T0.2 mL
mAb anti-Human EGF, S-146, Tracer (Biotin Labeled)MO-C40044TB0.1 mL
mAb anti-Human MCP-3, 113, DetectorMO-C40088A0.1 mg
mAb anti-Human MCP-3, 542, CaptureMO-C40088G0.1 mg
mAb anti-Human MCP-3, 113, Tracer (HRP Labeled)MO-C40088T0.2 mL
mAb anti-Human MCP-3, 113, Tracer (Biotin Labeled)MO-C40088TB0.1 mL
mAb anti-Human IL-16, 323, DetectorMO-C40089J0.1 mg
mAb anti-Human IL-16, 398, CaptureMO-C40089K0.1 mg
mAb anti-Human IL-16, 323, Tracer (HRP Labeled)MO-C40089T0.2 mL
mAb anti-Human GM-CSF, 59, CaptureMO-C40090B0.1 mg
mAb anti-Human GM-CSF, 429, DetectorMO-C40090D0.1 mg
mAb anti-Human GM-CSF, 429, Tracer (HRP Labeled)MO-C40090T0.2 mL
mAb anti-Human GM-CSF, 429, Tracer (Biotin Labeled)MO-C40090TB0.1 mL
mAb anti Human IL-18 clone 2A10, CaptureMO-C40094A0.1mg
mAb anti Human IL-18 clone 10H4, DetectorMO-C40094B0.1mg
mAb anti human IL-18 clone 10H4, Tracer (Biotin Labeled)MO-C40094TB0.1 mL
mAb anti Human IL-15 clone 5E8, CaptureMO-C40095A0.1mg
mAb anti Human IL-15 clone B1H6, DetectorMO-C40095B0.1mg
mAb anti human IL-15 clone B1H6, Tracer (Biotin labeled)MO-C40095TB0.1 mL
mAb anti-HIV-1 P24 (Core Protein), 473, DetectorMO-I40002A0.1 mg
mAb anti-HIV-1 P24 (Core Protein), 340, CaptureMO-I40002D20.1 mg
mAb anti-HIV-1 P24 (Core Protein), 473, Tracer (HRP), 0.2 mLMO-I40002T20.2 mL
mAb anti-Human PD-1 / CD279, 7G12, Tracer (Biotin labeled)MO-L40043TB0.1 mL
mAb anti Human PD-L1 clone 12B4, DetectorMO-L40044I0.1 mg
mAb anti Human PD-L1 clone 15G3, CaptureMO-L40044N0.1 mg
mAb anti human PD-L1 clone 12B4, Tracer (Biotin Labeled)MO-L40044TB0.1 mL
mAb anti-hGH, YC6, CaptureMO-M40012A0.1 mg
mAb anti-hGH, YC8, Tracer (HRP Labeled), 0.2 mLMO-M40012T0.2 mL
mAb anti-hGH, YC8, Tracer (Biotin Labeled), 0.1 mLMO-M40012TB0.1 mL
mAb anti-Human B2MG, D2E9, CaptureMO-M40021C0.1 mg
mAb anti-Human B2MG, D3A2, DetectorMO-M40021F0.1 mg
mAb anti-Human B2MG, D3A2, Tracer (HRP Labeled), 0.2mLMO-M40021T0.2 mL
mAb anti-human CRP, 63F4, CaptureMO-M40023A0.1 mg
mAb anti-human TSH, TSH-2, DetectorMO-M40046A0.1 mg
mAb anti-human TSH, TSH-1, CaptureMO-M40046B0.1 mg
mAb anti-human TSH, TSH-2, Tracer (HRP Labeled), 0.2 mLMO-M40046T0.2 mL
mAb anti-Human Prolactin, PRL-1, CaptureMO-M40047B0.5 mg
mAb anti-Human Prolactin, PRL-2, Tracer (HRP Labeled), 0.2 mLMO-M40047T0.2 mL
mAb anti-Human LH, LH-1, CaptureMO-M40048B0.5 mg
mAb anti-Human LH, LH-2, Tracer (HRP Labeled), 0.2 mLMO-M40048T0.2 mL
mAb anti-hCG, HCG-1, CaptureMO-M40049B0.5 mg
mAb anti-hCG, HCG-2, Tracer (HRP Labeled), 0.2 mLMO-M40049T0.2 mL
mAb anti-Human FSH, FSH-1, CaptureMO-M40050B0.5 mg
mAb anti-Human FSH, FSH-2, Tracer (HRP Labeled)MO-M40050T0.2 mL
mAb anti-Amyloid β Peptide 42, CA9 10C11, DetectorMO-M40093B0.5 mg
mAb anti-Amyloid β Peptide 42, CA9 10C11, Tracer (Biotin)MO-M40093TB0.1 mL
mAb anti-Amyloid β Peptide N-terminal, NT 5B8, CaptureMO-M40094D0.5 mg
mAb anti-Amyloid β Peptide 40, CV9 7B10, DetectorMO-M40095A0.1 mg
mAb anti-Amyloid β Peptide 40, CV9 7B10, Tracer (Biotin)MO-M40095TB0.1 mL
mAb anti-Human AFP, AFP-Y2, DetectorMO-T40007A0.1 mg
mAb anti-Human AFP, AFP-Y1, CaptureMO-T40007B0.1 mg
mAb anti-Human AFP, AFP-2, Tracer (HRP Labeled), 0.2 mLMO-T40007T0.2 mL
mAb anti-Human CEA, CEA-Y2, DetectorMO-T40051A0.1 mg
mAb anti-Human CEA, CEA-Y1, CaptureMO-T40051B0.1 mg
mAb anti-Human CEA, CEA-Y2, Tracer (HRP Labeled), 0.2 mLMO-T40051T0.2 mL
mAb anti-Human Free PSA, 103, DetectorMO-T40052A0.1 mg
mAb anti-Human Free PSA, 108, CaptureMO-T40052B0.1 mg
mAb anti-Human Free PSA, 103, Tracer (HRP Labeled), 0.2 mLMO-T40052T0.2 mL
mAb anti-Human PSA, CHYH1, CaptureMO-T40081A0.1 mg
mAb anti-Human PSA, CHYH2, DectectorMO-T40081B0.1 mg
mAb anti-Human PSA, CHYH2, Tracer (HRP Labeled), 0.2 mLMO-T40081T0.2 mL
Human Chorionic Gonadotrophin (hCG), 10 mgAP3000210 mg
Human Immunoglobulin G (IgG), 10 mgIG3000110 mg
Mouse Immunoglobulin G (IgG), 10 mgIG4100210 mg
Mouse Immunoglobulin G2b (IgG2b), 10 mgIG4100410 mg
Rat Immunoglobulin G (IgG)IG4200310 mg
Human Umbilical Cord Serum, 10 mLS3001010 mL
ELISA Coating (EC) Stabilizer, 500 mLS7001500 mL
Human IL-8 Matched Antibody Pair for ELISpotSL10008A5 × 96 wells
Human IL-8 Development Set for ELISpotSL10008B5 × 96 wells
Human IL-8 ELISpot KitSL10008E6 X 96 wells
Human MCAF (MCP-1) Matched Antibody Pair for ELISpotSL10009A5 × 96 wells
Human MCAF (MCP-1) Development Set for ELISpotSL10009B5 × 96 wells
Human MCAF (MCP-1) ELISpot KitSL10009E6 X 96 wells
Human GM-CSF Matched Antibody Pair for ELISpotSL10020A5 × 96 wells
Human GM-CSF Development Set for ELISpotSL10020B5 × 96 wells
Human GM-CSF ELISpot KitSL10020E6 X 96 wells
Human IFN-γ Matched Antibody Pair for ELISpotSL10024A5 × 96 wells
Human IFN-γ Development Set for ELISpotSL10024B5 × 96 wells
Human IFN-γ ELISpot KitSL10024E6 X 96 wells
Human IL-12 (P70) ELISpot KitSL10032E6 X 96 wells
TMB Solution (500 mL Part A & 500 mL Part B)SU60061.0 L
pAb Rabbit anti-HCV Virus, 1.0 mgAI20006P1.0 mg
pAb Rabbit anti-HIV-1 p24, 1.0 mgAI20008P1.0 mg
pAb anti-Human CRP, Tracer (HRP Labeled)AI20009P0.2 mL
pAb Rabbit anti-Mouse IgG , 1.0 mgAI500051.0 mg
pAb Rabbit anti-Mouse IgG - HRP Conjugated, 1.0 mLAI50005P1.0 mL
pAb Rabbit anti-hGH,AI50006P1.0 mg
pAb Chicken anti-human IL-8 (IgY fraction)AI600011.0 mg
pAb Rabbit anti-Human FPRL-1 2nd Extracellular LoopAI70001A0.1 mg
pAb Rabbit anti-Human FPRL-1 C-terminalAI70001B0.1 mg
pAb Rabbit anti-Human PML [Ring Finger Domain]AI70002A0.1 mg
pAb Rabbit anti-Human PML [B-box 1 domain]AI70002B0.1 mg
pAb Rabbit anti-Bcl-2AI70003A0.1 mg
pAb Rabbit anti-Phospho-Bcl-2 (Thr56)AI70003B0.1 mg
pAb Rabbit anti-Phospho-Bcl-xL (Thr115)AI70003D0.1 mg
pAb Rabbit anti-Phospho c-kit (Tyr719)AI70004A0.1 mg
pAb Rabbit anti-Phospho IKK-γ (Ser31)AI70005A0.1 mg
pAb Rabbit anti-NF-κB-p65 (RelA)AI70006A0.1 mg
pAb Rabbit anti-Phospho-NF-қB-p65 (Ser276)AI70007A0.1 mg
pAb Rabbit anti-Phospho-NF-қB-p65 (Ser468)AI70008A0.1 mg
pAb Rabbit anti-Phospho NF-қB-p105/p50 (Ser337)AI70009A0.1 mg
pAb Rabbit anti-Human Serum Albumin (HSA)AI800010.1 mg
pAb Rabbit anti-Human Fibrinogen, 0.1 mgAI800020.1 mg
pAb Rabbit anti-Human TransferrinAI800030.1 mg
pAb Rabbit anti-Human IgA, 0.5 mgAI800040.5 mg
pAb Rabbit anti-human IgM, 0.5 mgAI800050.5 mg
pAb Rabbit anti-Human TREK-1 (K2p2.1)AI80006A0.1 mg
pAb Rabbit anti-Mouse Kchip1AI800070.1 mg
pAb Rabbit anti-Mouse Kchip4AI800080.1 mg
pAb Rabbit anti-Mouse Kv4.3AI80010A0.1 mg
pAb Rabbit anti-Mouse TRPV1AI80011A0.1 mg
pAb Rabbit anti-Mouse TRPV3AI80012A0.1 mg
pAb Rabbit anti-Human JAK2AI80013A0.1 mg
pAb Rabbit anti-Human Glutathione S Transferase (GST), 0.1 mgAI800140.1 mg
pAb Rabbit anti-Human Amyloid beta peptide 42AI900010.1 mg
pAb Rabbit anti-Human Amyloid beta peptide 43AI900020.1 mg


" data-original="http://athens.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="Anogen">
Anogen
...
阅读详情
TATUA-logo-main.pngexocell.jpg

艾美捷科技代理Tatua大拓品牌。

▌公司介绍


大拓位于新西兰畜牧中心地带,是新西兰历史最悠久的乳制品公司,创立于1914年。大拓研发生产专业蛋白胨,用于诊断培养基、发酵培养基、益生菌、生物制药和细胞培养行业,其蛋白胨都符合清真和犹太洁食标准。

1749082208766(1).jpg


更多详情请咨询→

二维码图片.png

全国免费热线:400-6800-868

直拨专线:+86-027-59626688;18771997407

客服QQ一:17754422825;

客服QQ二:18771149750


▌产品系列


大拓能够提供多样化的蛋白胨组合,以适应全球发酵和益生菌培养基细分市场的一系列应用需求。我司代理的产品类别包括乳糖蛋白胨及植物蛋白胨。

  乳糖蛋白胨

大拓 (Tatua) 提供一系列源自新西兰、无BSE/TSE风险的纯净奶源的乳蛋白胨产品。

● 酪蛋白胨(清真胰蛋白胨):其化学组成、成分和物理特性均经过精心设计,以匹配更传统的胰蛋白酶消化酪蛋白(胰蛋白胨)产品的规格。

● 乳清蛋白胨(乳白蛋白酶解物):能够支持苛养菌的生长,常用于需要特定氨基酸谱的益生菌应用领域。


大拓 (Tatua) 的乳蛋白胨产品组合涵盖广泛的优势,包括:

● 过滤级产品:提供澄清度与热稳定性

● 非过滤级产品:更具成本效益

● 清真 (Halal) 与洁食 (Kosher) 认证

● 多种游离氨基酸谱 (FAA profiles):以支持最佳生长性能


ProductProtein SourceFilteredpHTotal NitrogenAmino NitrogenAN/TNAshFeatures / Benefits
EHCKCaseinNo6.613.80%5.50%39.90%3.50%● Cost effective nitrogen source
HCP275CaseinYes6.913.60%4.30%31.80%5.50%● Halal alternative to tryptone
● Meets pancreatic digest of casein USP criteria
HCP321CaseinYes6.813.60%5.80%42.50%4.50%● Halal alternative to tryptone
● Good source of free amino acids
HCP512CaseinYes6.814.30%2.60%18.20%4.00%● Specially designed for use in biopharma fermentations
Tatua 2400CaseinYes6.913.40%4.40%32.90%5.80%● Supports growth of fastidious bacteria
● Halal alternative to tryptone
Tatua 2016WheyYes6.412.20%4.90%40.40%4.50%● Supports growth of fastidious bacteria


  植物蛋白胨

大拓 (Tatua)将酶解技术和下游加工技术应用于非乳制品蛋白原料,提供无动物成分和/或无过敏原特性的蛋白胨解决方案,作为传统(动物源)蛋白胨的替代品。

● Tatua大豆蛋白胨:是某些诊断培养基配方(如 TSA 和 TSB)的重要组成部分,并且在益生菌发酵应用中表现成熟可靠。

● Tatua豌豆蛋白胨:旨在解决大豆蛋白胨可能引起的大豆过敏原问题而开发,适用于益生菌应用。

<
ProductProtein SourceFilteredpHTotal NitrogenAmino NitrogenAN/TNAshFeatures / Benefits
HSP320SoyYes6.99.20%2.50%26.90%7.10%● Good source of free amino acids
HSP348SoyNo79.10%1.70%18.60%7.80%● Cost effective nitrogen and carbohydrate source
HSP349SoyYes79.60%1.80%19.00%7.40%● Meets papaic digest of soy USP criteria
HSP429SoyYes7.19.80%2.70%27.00%8.80%● Supports growth of fastidious bacteria
● Stable in buffered solutions
Tatua 5260PeaYes6.413.60%4.40%32.30%4.80%● Good source of free amino acids
● Dairy-free
● Soy-free


▌产品优势


大拓微生物营养解决方案具有以下优势:

● 大拓用于生产蛋白胨的乳蛋白原料(酪蛋白和乳清蛋白)都是直接来源于新西兰自有农场的奶源,是唯一一家能够全方位供应乳蛋白原料的蛋白胨生产商

●  新西兰来源的乳蛋白原料符合无BSE/TSE要求

●  植物蛋白为非转基因来源

●  大批量生产(高达8MT)降低单位成本

●  FSSC 22000-Q 认证确保满足最高水平的质量要求

●  专业的研发团队能够根据不同培养基的需求提供定制化解决方案

● 出厂保质期为60个月


▌大拓蛋白胨的促生长性能


生长性能1.png

生长性能2.png

生长性能3.png

" data-original="http://athens.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="艾美捷科技代理Tatua大拓蛋白胨产品">
艾美捷科技代理Tatua大拓蛋白胨产品
...
阅读详情
6695f94d88a53.jpg

艾美捷科技代理Magtivio品牌磁珠产品


荷兰Magtivio BV是一家磁性微/纳米颗粒生产商,为生命科学和生物分析领域提供磁珠及完整试剂盒产品。Magtivio BV设计开发了两种类型的二氧化硅包覆氧化铁磁珠,其中包括:超顺磁

性磁珠,它们采用复合多孔结构设计,易于再悬浮,并表现出较低的沉降率;以及铁磁性磁珠,这些磁珠粒型由相对致密的核壳结构制成,具有强磁性,更适合大体积和粘性样品。末端官能

化的基团可以连接到两种磁珠类型的二氧化硅涂层。Magtivio BV的产品包括:


(1)核酸纯化:MagSi-(D)NA试剂盒和磁珠作为固体支持相,从病原体、植物和动物组织、体液和细胞中分离核酸。

(2)DNA纯化:MagSi试剂盒,用于测序应用中的PCR 纯化、DNA大小选择。

(3)免疫测定:MagSi链霉亲和素珠用作固相,易于结合生物素化的生物分子。

(4)蛋白质分析:具有改性表面的MagSi微珠,用于蛋白质的纯化和分离,用于质谱、蛋白质组学分析和生物标志物研究。

(5)研究工具:表面活化的MagSi微珠,用于固定蛋白质、肽、核酸或其他感兴趣的分子;MagSi 平台具有广泛的功能化可能性。

(6)LCMS样品制备:在LC-MS/MS分析之前,基于MagSiMUS磁珠的生物样品制备,用于蛋白质耗竭和从生物样品中去除其他干扰化合物。

(7)SafeQ:用于样本采集、储存和释放的解决方案,例如唾液采集试剂盒

(8)磁选机:用于从液体样品中磁分离MagSi和MagSiMUS磁珠。

(9)rQ " data-original="http://athens.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="艾美捷科技代理Magtivio品牌磁珠产品"> 艾美捷科技代理Magtivio品牌磁珠产品

...
阅读详情
Nanoprobes.jpg

Nanoprobes公司专业生产免疫金标记和免疫测定试验产品。其独特的金标技术使用化学交联的金属和纳米颗粒团簇作为标记。与胶体金颗粒静电吸附在抗体和蛋白质上的传统免疫金探针不同,本公司的金标是与生物分子在特定位点交联的不带电荷的分子。这使我们的探针具有胶体金不具备的范围和灵活性。我们的标记可以附着在任何带有反应基的分子上– 蛋白质、多肽、寡核苷酸、小分子和脂类 - 以检测和定位这些分子。其他标记可以与我们的金标共同使用,我们独特的荧光纳米金探针在一个探针中结合了纳米金(nanogold®)和荧光素,用于荧光和电镜两种技术共同进行样品成像。

 

Nanoprobes was founded in 1990 by Dr. James F. Hainfeld, along with a group of scientists who were also alumni of Brookhaven National Laboratory. The independent research facility they formed has allowed Dr. Hainfeld and his colleagues the freedom to pursue some of the greatest challenges in research: seeking cures for cancer and other diseases.

 

While part of the funding for these endeavors has come from research grants, another source had to be found, as the scientific community faces ever-increasing government cutbacks. To this end, Nanoprobes began to offer many of the nanoparticle technologies developed by its members for use in other scientists' research.

 

Nanoprobes公司主要产品:

AuroVist™ 15 nm & 1.9 nm X-ray Contrast Agent

Conjugates

Enhancement / Developers

EnzMet™ ultra-sensitive

Gold Nanomaterials: Functionalized Nanoparticles

Gold Nanoparticle Reagents

Histadine (His) Tag Labeling

Recombinant Protein Detection

FerroMag™ Magnetic nanoparticles

Negative Stains for EM

Xray Contrast Agents

<

更多详情请联系 

艾美捷科技有限公司

全国服务热线:400-6800-868

邮箱:sales@amyjet.com

网站:www.amyjet.com


" data-original="http://athens.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="Nanoprobes">
Nanoprobes
...
阅读详情
Abliance logo 2.5比1.png

艾美捷科技代理Abliance品牌全系列产品


Abliance是一家法国的抗体制造商和服务提供商,由专家组成的团队,在细胞培养、蛋白质工程和质量控制方面拥有深厚专业知识,专注为体外诊断(IVD)及科研领域提供高合规性抗体解决方案,满足研究和诊断工业市场的抗体需求。


▍Abliance公司产品提供丰富可选择的抗体库

多物种来源多特异性靶点 多样标记方式多级适用品质
anti-human Iganti-IgG, IgM, IgAfluorescentglobulins
anti-mouse and rabbit Iganti-IgGAMenzymaticaffinity purified antibodies
anti-goat, bovine, dog Ig ...anti-Fc and Fab fragmentsbiotinFab and F(ab')2 fragments


● Abliance的二抗产品为多克隆抗体,通过使用人或动物免疫球蛋白对实验动物(兔、山羊或绵羊)进行高效免疫后获得。收集的免疫血清除含有目标特异性抗体外,还包含非特异性抗体及血清杂蛋白。

● Globulins:经过系列非特异性纯化步骤(脱脂处理→硫酸铵沉淀→透析)后获得球蛋白组分,此中间产物适用于免疫沉淀技术。

● Affinity purified antibodies:随后通过亲和层析对抗体进行纯化,从而确保高特异性。此外,抗鼠/兔IgG(H+L)二抗需在装有人源IgA/IgG/IgM的凝胶层析柱上进行系统化吸附处理,确保其与人源IgA/IgG/IgM无交叉反应。

● Fragments:Abliance提供经酶切获得的F(ab')₂和Fab片段,适用于免疫组化/细胞学检测及流式细胞术等场景。相较于含Fc区的完整抗体,这些片段能显著降低非特异性结合。其更小的分子量可增强细胞和组织渗透性。

● Labeled antibodies:Abliance供应多样标记物复合体:球蛋白组分、纯化抗体及Fab/F(ab')₂片段,可与荧光染料(异硫氰酸荧光素)、酶类(过氧化物酶、碱性磷酸酶、β-半乳糖苷酶、葡萄糖氧化酶)及生物素进行偶联。


Abliance.png


▍Abliance部分产品列表

货号品名规格HostAntigen
BI 1014Anti-Human IgGAM Globulin4mg/2mlGoatHuman IgGAM
BI 1015Anti-Human IgG (H+L) Globulin4mg/2mlGoatHuman IgG (H+L)
BI 1016Anti-Human IgA (alpha) Globulin4mg/2mlGoatHuman IgA (alpha)
BI 1018Anti-Human IgG (gamma) Globulin4mg/2mlGoatHuman IgG (gamma)
BI 1019Anti-Human IgM (µ) Globulin4mg/2mlGoatHuman IgM (µ)
BI 1025Anti-Human albumin Globulin4mg/2mlGoatHuman albumin
BI 3014Anti-Human IgGAM Fab2mg/1mlGoatHuman IgGAM
BI 3015Anti-Human IgG (H+L) Fab2mg/1mlGoatHuman IgG (H+L)
BI 3016Anti-Human IgA (alpha) Fab2mg/1mlGoatHuman IgA (alpha)
BI 3018Anti-Human IgG (gamma) Fab2mg/1mlGoatHuman IgG (gamma)
BI 3019Anti-Human IgM (µ) Fab Goat2mg/1mlGoatHuman IgM (µ)
BI 3025Anti-Human albumin Fab2mg/1mlGoatHuman albumin
BI 4015Anti-Human IgG (H+L) F(ab')22mg/1mlGoatHuman IgG (H+L)
BI 4016Anti-Human IgA (alpha) F(ab')22mg/1mlGoatHuman IgA (alpha)
BI 4018Anti-Human IgG (gamma) F(ab')22mg/1mlGoatHuman IgG (gamma)
BI 4019Anti-Human IgM (µ) F(ab')22mg/1mlGoatHuman IgM (µ)
BI 4025Anti-Human albumin F(ab')22mg/1mlGoatHuman albumin
BI 3414Anti-Human IgGAM Fab HRP1mlGoatHuman IgGAM
BI 3415Anti-Human IgG (H+L) Fab HRP1mlGoatHuman IgG (H+L)
BI 3416Anti-Human IgA (alpha) Fab HRP1mlGoatHuman IgA (alpha)
BI 3418Anti-Human IgG (gamma) Fab HRP1mlGoatHuman IgG (gamma)
BI 3419Anti-Human IgM (µ) Fab HRP1mlGoatHuman IgM (µ)
BI 3425Anti-Human albumin Fab HRP1mlGoatHuman albumin
BI 4414Anti-Human IgGAM F(ab')2 HRP1mlGoatHuman IgGAM
BI 4415Anti-Human IgG (H+L) F(ab')2 HRP1mlGoatHuman IgG (H+L)
BI 4419Anti-Human IgM (µ) F(ab')2 HRP1mlGoatHuman IgM (µ)
BI 4425Anti-Human albumin F(ab')2 HRP1mlGoatHuman albumin


" data-original="http://athens.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="艾美捷科技代理Abliance品牌全系列产品">
艾美捷科技代理Abliance品牌全系列产品
...
阅读详情
Hello Bio Ltd LOGO 2.5比1.jpgexocell.jpg

艾美捷科技代理Hello Bio 品牌。

Roboscreen Diagnostics公司,正式名称为ROBOSCREEN GmbH,是一家专注于研发和生产高质量诊断工具的公司,在qPCR应用开发、单克隆抗体的产生以及它们在免疫化学测试构建中的应用方面具有高水平的专业知识。


Hello Bio由一群经验丰富的科学家和化学家组成,他们真诚地希望支持生命科学研究。目标是制造和供应一系列高性价比的生命科学生化制品、抗体和试剂,以便尽可能多的研究人员能够负担得起。


Hello Bio Ltd的产品线非常丰富,涵盖了多个生命科学领域的关键试剂和工具,包括:

(1)激动剂、拮抗剂、抑制剂和激活剂:这些产品被广泛用于信号转导系统研究,以及药物筛选和开发等领域。

(2)酶抑制剂和激活剂:用于调节酶的活性,是研究细胞代谢和信号传导的重要工具。

(3)信号通路研究工具:包括各种信号分子和信号通路调节剂,有助于揭示细胞间的通讯机制。

(4)受体配体:用于研究受体与配体之间的相互作用,以及药物与受体的结合特性。

(5)离子通道调节器:用于调节离子通道的活性,是研究神经传导、肌肉收缩等生理过程的重要工具。

(6)表观遗传工具:用于研究表观遗传机制,如DNA甲基化、组蛋白修饰等,对于理解基因表达和疾病发生具有重要意义。

(7)干细胞调节剂:用于调节干细胞的增殖和分化,是研究干细胞生物学和再生医学的重要工具。

此外,Hello Bio Ltd还提供定制合成服务,可以根据客户的具体需求合成特定的化合物或试剂。




<<<<< " data-original="http://athens.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="艾美捷科技代理Hello Bio品牌">
艾美捷科技代理Hello Bio品牌
...
阅读详情
Schircks Laboratories LOGO.jpg


艾美捷科技代理Schircks Laboratories品牌。

瑞士Schircks Laboratories由B.Schircks博士于1980年创立,主要生产蝶啶及蝶啶类化合物(Pteridines)。至今,Schircks实验室合成了100多种蝶啶类化合物,主要用于科学研究和临床诊断应用。产品包括:

<
11.1806-(L-1,2,3-Trihydroxybutyl)-pterin [Rhamnopterin]
11.182(6R,S)-5,6,7,8-Tetrahydro-L-rhamnopterin dihydrochloride
11.203L-Biopterin [L-erythro-Biopterin] 
11.2067,8-Dihydro-L-biopterin
11.209(6R,S)-5,6,7,8-Tetrahydro-L-biopterin dihydrochloride 
11.212(6R)-5,6,7,8-Tetrahydro-L-biopterin dihydrochloride
11.213(6R)-5,6,7,8-Tetrahydro-L-biopterin dihydrochloride
11.215(6S)-5,6,7,8-Tetrahydro-L-biopterin sulfate
11.216(6S)-5,6,7,8-Tetrahydro-L-biopterin sulfate
11.217(6R)-5-Methyl-5,6,7,8-tetrahydro-L-biopterin dihydrochloride
11.218D-Biopterin [D-erythro-Biopterin]
11.220(6R,S)-5,6,7,8-Tetrahydro-D-biopterin dihydrochloride
11.221D-threo-Biopterin [Dictyopterin] 
11.223(6R,S)-5,6,7,8-Tetrahydro-D-threo-biopterin dihydrochloride 
11.228Deoxysepiapterin
11.2296-((1R,S)-Hydroxypropyl)pterin [(1'R,S)-2'-Deoxybiopterin]
11.2317-Biopterin 
11.2347-Tetrahydro-L-biopterin dihydrochloride
11.260Oncopterin
11.2704-Hydroxy-6-(L-erythro-1,2-dihydroxy-propyl)-2-(methylthio)pteridine
11.2804-Amino-L-biopterin [2,4-Diamino-6-(L-erythro-1',2'-dihydroxypropyl)pteridine]
11.2824-Amino-(6R,S)-5,6,7,8-tetrahydro-L-biopterin dihydrochloride
11.2834-Amino-(6R)-5,6,7,8-tetrahydro-L-biopterin dihydrochloride
11.303D-Neopterin [D-erythro-Neopterin] 
11.3067,8-Dihydro-D-neopterin  
11.3077,8-Dihydro-D-neopterin-3’-triphosphate  (Please refer to our reference 8)
11.309(6R,S)-5,6,7,8-Tetrahydro-D-neopterin dihydrochloride
11.314D-Neopterin-3’-monophosphate, lithium salt
11.3157,8-Dihydro-D-neopterin-3’-monophosphate, lithium salt  
11.3203'-Hydroxy-D-sepiapterin
11.3307-Neopterin  
11.340L-Monapterin [L-threo-Neopterin]
11.3457,8-Dihydro-L-monapterin
11.346(6R,S)-5,6,7,8-Tetrahydro-L-monapterin dihydrochloride
11.349D-Monapterin [D-threo-Neopterin]
11.403Pterin-6-carboxylic acid
11.409Pterin-7-carboxylic acid
11.4156-Formylpterin [Pterin-6-aldehyde]
11.4166-Formyl-7,8-dihydropterin
11.418Acetyl-6-formylpterin
11.4206-Hydroxymethylpterin
11.4216-Hydroxymethyl-7,8-dihydropterin hydrochloride
11.4226-Hydroxymethyl-7,8-dihydropterin-diphosphate    (Please refer to our reference 8)
11.423(6R,S)-6-Hydroxymethyl-5,6,7,8-tetrahydropterin dihydrochloride
11.4296-Hydroxymethylpterin-monophosphate 
11.4386-Hydroxymethylpterin-diphosphate, lithium salt  
11.4806-Methylpterin
11.4816-Methyl-7,8-dihydropterin hydrochloride
11.483(6R,S)-6-Methyl-5,6,7,8-tetrahydropterin dihydrochloride
11.5036,7-Dimethylpterin
11.5066,7-Dimethyl-7,8-dihydropterin monohydrochloride
11.5096,7-Dimethyl-5,6,7,8-tetrahydropterin monohydrochloride
11.703Leucopterin
11.713Xanthopterin
11.716Dihydroxanthopterin
11.723Isoxanthopterin
11.903Pterin
11.9067,8-Dihydropterin  (Please refer to our reference 20)
11.9095,6,7,8-Tetrahydropterin dihydrochloride
13.103Lumazine
13.2036-Hydroxylumazine
13.2066-Hydroxy-7,8-dihydrolumazine
13.2207-Hydroxylumazine
16.113Pteroic acid
16.123N10-(Trifluoroacetyl)pteroic acid
16.14010-Formylpteroic acid
16.203Folic acid  
16.2067,8-Dihydrofolic acid
16.208(6S)-5,6,7,8-Tetrahydrofolic acid trihydrochloride  
16.209(6R,S)-5,6,7,8-Tetrahydrofolic acid trihydrochloride 
16.21110-Methylfolic acid
16.21510-Formylfolic acid  
16.21710-Formyl-5,6,7,8-tetrahydrofolic acid  (Please refer to our reference 19)
16.220(6R,S)-5-Formyl-5,6,7,8-tetrahydrofolic acid, calcium salt 
16.222(6R)-5-Formyl-5,6,7,8-tetrahydrofolic acid, calcium salt (unnatural calcium folinate)  
16.230(6R,S)-5,10-Methenyl-5,6,7,8-tetrahydrofolic acid chloride
16.233(6R,S)-5-Methyl-5,6-dihydrofolic acid, ammonium salt  
16.235(6R,S)-5-Methyl-5,6,7,8-tetrahydrofolic acid, calcium salt
16.236(6S)-5-Methyl-5,6,7,8-tetrahydrofolic acid, calcium salt
16.243(6R,S)-5-Methyl-5,6,7,8-tetrahydropteroyltri-γ-L-glutamic acid trihydrochloride
16.244(6R,S)-5-Methyl-5,6,7,8-tetrahydropteroyltetra-γ-L-glutamic acid trihydrochloride
16.252Pteroyldi-γ-L-glutamic acid  
16.253Pteroyltri-γ-L-glutamic acid   has been discontinued
16.254Pteroyltetra-γ-L-glutamic acid  
16.255Pteroylpenta-γ-L-glutamic acid  has been discontinued
16.266Pteroylhexa-γ-L-glutamic acid, ammonium salt
16.267Pteroylhepta-γ-L-glutamic acid, ammonium salt  
16.280(6R,S)-5-Formyl-5,6,7,8-tetrahydropteroic acid
16.282(6R,S)-5-Formyl-5,6,7,8-tetrahydropteroyldi-γ-L-glutamic acid, lithium salt has been discontinued
16.283(6R,S)-5-Formyl-5,6,7,8-tetrahydropteroyltri-γ-L-glutamic acid, lithium salt has been discontinued
16.284(6R,S)-5-Formyl-5,6,7,8-tetrahydropteroyltetra-γ-L-glutamic acid, lithium salt
16.285(6R,S)-5-Formyl-5,6,7,8-tetrahydropteroylpenta-γ-L-glutamic acid, lithium salt
16.286(6R,S)-5-Formyl-5,6,7,8-tetrahydropteroylhexa-γ-L-glutamic acid, lithium salt
16.330Aminopterin [4-Aminofolic acid]
16.4034-Amino-10-methylpteroic acid (APA, DAMPA)
16.411Methotrexate  [4-Amino-10-methylpteroyl-γ-L-glutamic acid]
16.4124-Amino-10-methylpteroyldi-γ-L-glutamic acid, ammonium salt [Methotrexate diglutamate]
16.4134-Amino-10-methylpteroyltri-γ-L-glutamic acid, ammonium salt [Methotrexate triglutamate] 
16.4144-Amino-10-methylpteroyltetra-γ-L-glutamic acid, ammonium salt [Methotrexate tetraglutamate] 
16.4154-Amino-10-methylpteroylpenta-γ-L-glutamic acid, ammonium salt [Methotrexate pentaglutamate]
16.4164-Amino-10-methylpteroylhexa-γ-L-glutamic acid, ammonium salt [Methotrexate hexaglutamate]
16.4174-Amino-10-methylpteroylhepta-γ-L-glutamic acid, ammonium salt [Methotrexate heptaglutamate] 
16.5007-Hydroxymethotrexate   
16.701p-Aminobenzoyl-L-glutamic acid
16.702p-Aminobenzoyldi-γ-L-glutamic acid, ammonium salt  
16.703p-Aminobenzoyltri-γ-L-glutamic acid, ammonium salt  
16.704p-Aminobenzoyltetra-γ-L-glutamic acid, ammonium salt  
16.705p-Aminobenzoylpenta-γ-L-glutamic acid, ammonium salt  
16.706p-Aminobenzoylhexa-γ-L-glutamic acid,  ammonium salt 
16.707p-Aminobenzoylhepta-γ-L-glutamic acid, ammonium salt  has been discontinued
16.901Z-Glu-OtBu
16.902Z-Glu2-OtBu3
16.903Z-Glu3-OtBu4  
16.904Z-Glu4-OtBu5  
16.905Z-Glu5-OtBu6  
16.906Z-Glu6-OtBu7  
91.303D-(5-15N)-Neopterin
96.203(5-15N)-Folic acid 
< " data-original="http://athens.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="艾美捷科技代理Schircks Laboratories品牌">
艾美捷科技代理Schircks Laboratories品牌
...
阅读详情
List Labs.jpg

List Labs公司成立于1978年,位于美国加州硅谷,是一家专业提供各类微生物Toxin的生物技术公司。

 

Our company was founded in 1978 by Linda Shoer. Cholera toxin, the first product, was sought after by those doing research in signal transduction and by others using the toxin B subunit to label neurons. At that time there were no commercial suppliers of this toxin. Our company has always focused on quality bacterial toxins, which you can depend on for your research. Because toxins have been the basis for many vaccines, List Labs products have supported vaccine development. List Labs was the first to commercialize many bacterial toxins for research, including C.difficile toxins and pertussis toxin. Today, we remain uniquely focused on manufacturing, offering and supporting a wide range of bacterial products.

 

List Labs' heart is in the science and the discovery of innovative reagents. Our office is located in Campbell, California, in Silicon Valley. We serve the global research community with an expanding group of distributors. Years of experience translate into expertise in the production, shipment and handling of dangerous goods. If you have questions about any of our products or services, contact us.

 

List Biological Labs的主要产品包括:

Anthrax Toxins

Antisera & Antibodies

Botulinum Toxins

Cholera Toxins

Difficile Toxins

Diphtheria Toxin & Crm

Exotoxin A

Fret Peptides, Native Substrates & Receptors

Lipopolysaccharides

Pertussis Toxins & Virulence Factors

Shiga Toxins

Staphylococcal Toxins

Tetanus Toxins & Related Products

Toxoids

Vaccine Carrier Proteins And Adjuvants

<

更多详情请联系 

艾美捷科技有限公司

全国服务热线:400-6800-868

邮箱:sales@amyjet.com

网站:www.amyjet.com

" data-original="http://athens.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="List Labs">
List Labs
...
阅读详情
logo.png

<

艾美捷科技代理Aneufast品牌全系列产品


Aneufast是一家专业生产诊断非整倍体染色体试剂盒的生物公司。QF-PCR试剂盒Aneufast公司的核心产品。Aneufast™ QF-PCR试剂盒包含六组多重标记系统,基于短串联重复序列(STRs)扩增技术,可同步检测精选微卫星位点及性别决定基因(Amelogenin-SRY)。该设计通过单次反应实现多染色体同步筛查,显著提升检测效率。此标记组合可精准识别13、18、21号常染色体及X、Y性染色体的非整倍体异常。


Aneufast页面.png


Aneufast™ QF-PCR试剂盒具有以下特点:

● 五色荧光DNA片段分析系统:采用五重荧光标记技术,实现单次电泳中13/18/21/X/Y染色体STR标记的同步检测与区分;

● 即用型PCR预混体系:含热启动聚合酶及优化缓冲液,操作仅需 "加DNA→扩增" 两步;

● 超快速检测流程:样本到结果仅需3.5小时

● 染色体特定位点备份设计:每套试剂盒额外提供 13/18/21/X/Y染色体专属STR标记(独立分装)

● 全平台兼容性:经优化适配ABI全系列基因分析仪,如3500/3500xL Dx,SeqStudio Flex和7500 Fast Dx

● 国际质量认证:符合欧盟体外诊断指令98/79/EC;通过 ISO 9001:2000 及 ISO 13485:2003 医疗器械生产双认证



" data-original="http://athens.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="艾美捷科技代理Aneufast品牌全系列产品">
艾美捷科技代理Aneufast品牌全系列产品
...
阅读详情

城市分站
联系我们

地址:武汉市洪山区光谷大道35号光谷总部国际时代 二期1栋1301

电话:18771997407

传真:15172469628

邮箱:sales@amyjet.com

0.2113

Copyright © 2026 Powered by Athens Research&Technology中国区代理商/公司/官网   鄂ICP备10204150号-10 sitemap